New diabetes pill shows promise in major trial
NCT ID NCT01413204
Summary
This study tested a new oral medication called TA-7284 to see if it could help control blood sugar in adults with type 2 diabetes. For 24 weeks, 272 Japanese participants whose diabetes wasn't well-managed by diet and exercise alone received either a low dose, high dose, or a placebo pill. Researchers measured changes in long-term blood sugar levels (HbA1c) and monitored safety to see if the drug was effective and well-tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Chūbu, Japan
-
Reserch site
Kanto, Japan
-
Reserch site
Kinki, Japan
-
Reserch site
Shikoku, Japan
-
Reserch site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.